You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
恆指跌幅擴至近400點失二萬四關 中生製藥遭主要股減持股價挫6%失配售價
阿思達克 04-21 09:50
中生製藥(01177.HK)主要股東兼首席執行長謝炳以每股11.35元(較昨天收市價折讓近4.5%)向獨立第三方配售2億股,套約22.7億元,完成後謝氏持股量將由11%降至9.4%。該股繼昨天回補3月9日部分下跌裂口位後,今早扭兩連漲考驗10天線(11.21元),最低見11.14元,守穩50天線(11.1元),現造11.18元,回吐5.9%,為最傷藍籌,成交受配股上板帶動增至2.38億股,涉資27億元。

IMF總裁Kristalina Georgieva指,新冠肺炎疫情是大蕭條以來史無前例危機,料今年將有約170個國家經濟呈負增長,加上紐約5月期油崩瀉至歷來首呈負數,以及市場料本周美企季績及經濟數據將續令人失望,投資者先後獲利回吐,道指昨晚由逾一個月高位急吐592點或2.4%失守23,700關。不過,道指期貨曾彈逾百點。亞太區股市今早全面受壓。本港至3月止三個月,失業率環比續升0.5個百點至4.2%,創逾9年高,也高於市場預期升至4%。港股繼昨天反覆回軟後,今早低開82點或0.3%,跌幅擴至390點或1.6%,報23,940,成交額179億元。藍籌股普遍跌逾1%-3%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account